As a result of that review, we have been advised by our Scientific Advisory Board (SAB) to fund a second year of research for both our current projects:
- immunotherapy to treat childhood brain tumours
- treatment and improved detection of osteosarcoma
Any further call for funding applications during 2018 will be announced later in 2018.
If you would like to register your interest so we can get in touch once the applications open, please email – email@example.com